Article thumbnail

A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

By AG Jackson, HN Kløverpris, A Handley, P Hayes, J Gilmour, M Atkins, B Walker, J Ackland, M Sullivan and P Goulder
Publisher: Springer Nature
Year: 2012
DOI identifier: 10.1186/1742-4690-9-s2-o54
OAI identifier:
Provided by: MUCC (Crossref)

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles